Plain-English translation of NCT05588128 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Prostate Cancer research guide →This study follows men whose prostate cancer has come back after surgery or radiation therapy. Researchers will use a new type of imaging scan called PET to find small areas of cancer that standard scans might miss, and track how these areas grow or change over five years. The goal is to understand how this cancer evolves in individual patients so doctors can better predict and treat recurrent prostate cancer in the future.
After prostate cancer treatment, some men's PSA levels rise again (a sign of recurrence), but standard imaging scans don't show where the cancer is hiding. This medication offers a better way to find these hidden cancers early, but doctors don't yet know how these lesions develop over time or what they mean for each patient's future.
You likely qualify if…
You likely don't qualify if…
You'll visit the NIH clinic approximately every 3 months for PSA blood tests to monitor your cancer marker. You'll also have imaging scans—either every 6 months or annually depending on your initial scan results—to see how any cancer lesions are changing over time. In total, you'll be followed for up to 5 years with regular clinic visits, blood work, and imaging studies to help doctors understand how your cancer evolves.
AI-generated summary from trial data · Sep 11, 2026 · Not medical advice
United States